Effect of the acyl-CoA:cholesterol acyltransferase inhibitor, E5324, on experimental atherosclerosis in rabbits

This publication has 19 references indexed in Scilit:

• Comparison of CI-976, an ACAT inhibitor, and selected lipid-lowering agents for antiatherosclerotic activity in iliac-femoral and thoracic aortic lesions. A biochemical, morphological, and morphometric evaluation.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
• Antiatherosclerotic agents. A structurally novel bivalent inhibitor of AcylCoA:cholesterol O-acyltransferase with systemic activity
  Journal of Medicinal Chemistry, 1990
• Antiatherosclerotic and antihyperlipidemic effects of octimibate sodium in rabbits
  Atherosclerosis, 1988
• Chlorpromazine inhibits arterial ACAT and reduces arterial cholesterol and cholesteryl ester accumulation in cholesterol-fed rabbits.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1986
• Role of acyl-CoA: cholesterol acyltransferase in cellular cholesterol metabolism.
  Journal of Lipid Research, 1985
• Reduced cholesterol transmucosal transport in rats with inhibited mucosal acyl CoA:cholesterol acyltransferase and normal pancreatic function.
  Journal of Lipid Research, 1984
• Role of acyl CoA:cholesterol acyltransferase in cholesterol absorption and its inhibition by 57-118 in the rabbit.
  Journal of Lipid Research, 1983
• The effect of N-(α-Methylbenzyl) linoleamide on experimental atherosclerosis in rabbits
  Journal of Atherosclerosis Research, 1969
• Cholesterol Ester Metabolism
  Physiological Reviews, 1965
• Changes in Lipid Composition of Lymph During Cholesterol Absorption in the Rat
  American Journal of Physiology-Legacy Content, 1957